Drug General Information
Drug ID
D03KPZ
Former ID
DNC000436
Drug Name
Ciprofloxacin+dexamethasone
Drug Type
Small molecular drug
Indication Acute otitis media; Otitis externa [ICD9: 017.40, 055.2, 380, 381.0, 381.1, 381.2, 381.3, 381.4, 382; ICD10:H60, H65-H67] Approved [536222]
Company
Alcon
Structure
Download
2D MOL

3D MOL

Formula
C39H47F2N3O8
Canonical SMILES
CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C.<br />C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
InChI
1S/C22H29FO5.C17H18FN3O3/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24;18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3;7-10,19H,1-6H2,(H,23,24)/t12-,15+,16+,17+,19+,20+,21+,22+;/m1./s1
InChIKey
NTRHYMXQWWPZDD-WKSAPEMMSA-N
CAS Number
CAS 85721-33-1
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
J01MA02
SuperDrug CAS ID
cas=085721331
Target and Pathway
Target(s) DNA topoisomerase II Target Info Binder [536222]
References
Ref 536222Emerging therapies for the treatment and prevention of otitis media. Expert Opin Emerg Drugs. 2006 May;11(2):251-64.
Ref 536222Emerging therapies for the treatment and prevention of otitis media. Expert Opin Emerg Drugs. 2006 May;11(2):251-64.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.